Autophagy and apoptosis in hepatocellular carcinoma induced by EF25-(GSH)2: a novel curcumin analog.
Curcumin, a spice component as well as a traditional Asian medicine, has been reported to inhibit proliferation of a variety of cancer cells but is limited in application due to its low potency and bioavailability. Here, we have assessed the therapeutic effects of a novel and water soluble curcumin...
Main Authors: | Tao Zhou, Lili Ye, Yu Bai, Aiming Sun, Bryan Cox, Dahai Liu, Yong Li, Dennis Liotta, James P Snyder, Haian Fu, Bei Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0107876 |
Similar Items
-
In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.
by: Haitao Liu, et al.
Published: (2012-01-01) -
Bioactivities of EF24, a Novel Curcumin Analog: A Review
by: Yonghan He, et al.
Published: (2018-12-01) -
Anticancer effects of monocarbonyl analogs of curcumin: oxidative stress, nuclear translocation and modulation of AP-1 and NF-κB
by: Brian Adams, et al.
Published: (2015-01-01) -
Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors
by: Turker Mitchell S, et al.
Published: (2009-12-01) -
The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
by: Chuan He Yang, et al.
Published: (2013-01-01)